Analyst stock forecast
Alnylam Pharmaceuticals Forecast: $370.20 Analyst Target
ALNY has a $370.20 target, Buy rating and 26 analysts. As of 2026-08-22.
Direct answer
Alnylam Pharmaceuticals's average price target is $370.20.
The target implies +56.7% from the recorded current price, and the consensus rating is Buy.
The low target implies -2.6%, the high target implies +126.9%, and the range spans 129.5% of the current price.
Forecast evidence checked August 22, 2026.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $236.22
- Average price target
- $370.20
- High price target
- $536.00
- Low price target
- $230.00
- Low target gap
- -2.6%
- Target upside
- +56.7%
- High target gap
- +126.9%
- Target range width
- 129.5%
- Consensus rating
- Buy
- Analysts
- 26
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is Alnylam Pharmaceuticals's average price target?
Alnylam Pharmaceuticals's verified average price target is $370.20. The target range is $230.00 to $536.00.
How far are Alnylam Pharmaceuticals's low and high targets from the recorded price?
The low target implies -2.6%, while the high target implies +126.9%.
How many analysts are included in Alnylam Pharmaceuticals's consensus?
The verified consensus includes 26 analysts.
How is Alnylam Pharmaceuticals's target upside or downside calculated?
The average target of $370.20 is divided by the recorded price of $236.22, then one is subtracted to produce +56.7%. This does not guarantee a future return.
When was Alnylam Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.